Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анна Николаевна Дутчак, Ольга Богдановна СиноверскаяfiledCriticalАнна Николаевна Дутчак
Priority to UAU201113952UpriorityCriticalpatent/UA69825U/en
Publication of UA69825UpublicationCriticalpatent/UA69825U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
A method for treating atopic dermatitis in the children comprises antihistamine drugs, immunomodulators, and topical drugs. Licopid in tablets 1 mg is used as immunomodulator for three months at a dose of one tablet once a day for children aged from 1 to 6 years and twice a day for children aged from 7 to 18 years. In addition, Magne-Bis provided as oral solution at a dose of 10 mg/kg/day of magnesium divided in two doses for one month since the first day of the therapy.
UAU201113952U2011-11-282011-11-28Method for treating atopic dermatitis in children
UA69825U
(en)
Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect.